Author:
Bhattacharya Niranjan,Chettri M. K.,Chettri M. K.
Reference18 articles.
1. Sivasankaran S. Restrictive cardiomyopathy in India: the story of a vanishing mystery: global burden of cardiovascular disease. Heart. 2009;95:9–14. doi:
10.1136/hrt.2008.148437
.
2. Henning RJ. Stem cells in cardiac repair. Future Cardiol. 2011;7(1):99–117.
3. Tang XL, Rokosh G, Sanganalmath SK, Yuan F, Sato H, Mu J, Dai S, Li C, Chen N, Peng Y, Dawn B, Hunt G, Leri A, Kajstura J, Tiwari S, Shirk G, Anversa P, Bolli R. Intracoronary administration of cardiac progenitor cells alleviates left ventricular dysfunction in rats with a 30-day-old infarction. Circulation. 2010; 121(2):293–305.
4. Emanueli C, Lako M, Stojkovic M, Madeddu P. In search of the best candidate for regeneration of ischemic tissues: are embryonic/fetal stem cells more advantageous than adult counterparts? Thromb Haemost. 2005;94(4):738–49.
5. Djouad F, Bouffi C, Ghannam S, Noël D, Jorgensen C. Mesenchymal stem cells: innovative therapeutic tools for rheumatic diseases. Nat Rev Rheumatol. 2009;5(7):392–9.